Reactive arthropathy with neither the triggering infection site nor the affected joint specified — the fallback code when documentation lacks both identifiers.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- General
Documentation tips
What should appear in the chart to support M02.9.
Source · Editorial brief grounded in 4 cited references ↓
- Document the specific joint(s) affected by name and laterality (right/left) so a site-specific M02 subcode can be assigned instead of M02.9.
- Identify and record the preceding or concurrent infection (e.g., chlamydial urethritis, Salmonella gastroenteritis) — M02.9 describes a manifestation, so the underlying condition should be coded as well when known.
- Note whether imaging (X-ray, MRI, ultrasound) shows joint effusion, synovitis, or periarticular changes to support the reactive arthropathy diagnosis and justify the encounter.
- Record the temporal relationship between the triggering infection and the onset of joint symptoms — typically within days to weeks — to support clinical plausibility on audit.
- If Reiter's syndrome (reactive triad of arthritis, urethritis, conjunctivitis) is suspected, document each component explicitly; the M02.3x series provides more specific coding.
Related CPT procedures
Procedure codes commonly billed with M02.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M02.9 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M02.9 when the joint is actually documented — if the provider names the joint and side, drop to the appropriate M02.3x or M02.8x subcode; M02.9 is unspecified by site, not just by etiology.
- Failing to code the underlying triggering infection separately — M02.9 is flagged as a manifestation code, meaning it describes a secondary condition; omitting the primary infection code is a sequencing error.
- Confusing reactive arthropathy with septic arthritis — M02 codes apply only when the infecting organism is absent from the joint itself; if organism presence in the joint is confirmed or suspected, M00 (pyogenic arthritis) is the correct category.
- Assigning M02.9 when M02.89 (other reactive arthropathies, multiple sites) is more accurate — if the provider documents multiple joints are involved, M02.89 captures that specificity better than M02.9.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M02.9 is the catch-all code within the M02 category for reactive arthropathy when the clinical documentation does not specify the joint involved, the laterality, or the nature of the preceding infection. Reactive arthropathy is joint inflammation triggered by an infection elsewhere in the body — typically genitourinary or gastrointestinal — where the organism itself is not present in the joint. Because M02.9 describes a manifestation of an underlying disease rather than the disease itself, coders must also code the underlying triggering condition when it is known and documented.
The M02 category offers highly specific subcodes by site and laterality (e.g., M02.311 for Reiter's disease of the right shoulder, M02.872 for other reactive arthropathies of the left ankle and foot). M02.9 should only be used when specificity is genuinely unavailable — not as a shortcut. If the joint is documented but the trigger is unknown, a site-specific M02.8x9 code is more accurate. If the trigger is documented but the joint is not, query the provider before defaulting to M02.9.
In an orthopedic setting, reactive arthropathy may present after a patient has been treated elsewhere for a genitourinary or enteric infection and now arrives with joint complaints. Accurate coding requires the physician to document the suspected or confirmed triggering infection, the joint(s) involved, and laterality. Without those elements, M02.9 is billable but exposes the claim to specificity-related payer scrutiny.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01When is M02.9 the correct code rather than a more specific M02 subcode?
02Does M02.9 require an additional code for the underlying infection?
03Can M02.9 be used for Reiter's syndrome?
04What is the difference between M02.9 and M02.89?
05Is M02.9 valid for inpatient hospital claims?
06How does reactive arthropathy differ from septic arthritis for coding purposes?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M00-M02/M02-/M02.9
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02.9
- 04cms.govhttps://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf
Mira Scribe
Mira's AI scribe captures the joint name, laterality, and any documented preceding infection (site, organism, and timing) from the encounter note, then flags when M02.9 is about to be assigned and prompts the coder to check whether a site-specific M02 subcode applies. This prevents unnecessary use of the unspecified fallback and reduces the risk of a payer specificity challenge or manifestation-code sequencing error.
See how Mira captures M02.9 documentation